First Device Qualifies For Add-On Payment; CMS Retains Proposed Threshold
This article was originally published in The Gray Sheet
Executive Summary
The device industry's hopes to reduce the Centers for Medicare & Medicaid Services' new technology "add-on" payment threshold are riding on a provision in the House's "Medicare Prescription Drug & Modernization Act" of 2003 (HR 1)
You may also be interested in...
New Tech “Add-On” Payments Sought By Hospital On Behalf Of Firms
CardiacAssist hopes to obtain new technology "add-on" inpatient reimbursement for its TandemHeart percutaneous vascular assist device (PVAD), which will be used in an estimated 200 cardiogenic shock cases in 2005
New Tech “Add-On” Payments Sought By Hospital On Behalf Of Firms
CardiacAssist hopes to obtain new technology "add-on" inpatient reimbursement for its TandemHeart percutaneous vascular assist device (PVAD), which will be used in an estimated 200 cardiogenic shock cases in 2005
New tech add-on payments
Twelve applications are pending at CMS, following enactment of new Medicare provisions easing qualifying criteria for the payments, AdvaMed notes. Six of the applications are new. Before the law's passage, Medtronic's InFuse bone graft was the only device to qualify (1"The Gray Sheet" Aug. 4, 2003, p. 6)...